Literature DB >> 8977229

Nuclear import of HIV-1 DNA in resting CD4+ T cells requires a cyclosporin A-sensitive pathway.

Y Sun1, L M Pinchuk, M B Agy, E A Clark.   

Abstract

Using PCR to monitor early (LTR/LTR (long terminal repeat)) and late (LTR/gag) products of reverse transcription and the formation of HIV-1 LTR circles (indicating nuclear import), we explored the relationship between T cell activation signals and early events in the life cycle of HIV-1 infection. The combination of TCR ligation with either CD28 cross-linking or exogenous IL-2 was required for HIV-1 LTR circle formation in resting CD4+ T cells. Ligation of the TCR or CD28 receptors or addition of IL-2 alone did not induce this process. However, cross-linking the TCR, or IL-2 alone, unlike CD28 ligation, could induce the completion of viral reverse transcription. In contrast, the initiation of HIV-1 reverse transcription could occur in resting CD4+ T cells without any stimulation. Cyclosporin A (CsA), an inhibitor of T cell activation, completely blocked HIV-1 DNA nuclear import in activated CD4+ T cells. The completion of HIV-1 reverse transcription was blocked by CsA in infected CD4+ T cells activated by TCR ligation and IL-2, but not in cells stimulated by TCR and CD28 ligation. The costimulation of CD3 and CD28 mAbs in the presence of IL-2 could not overcome the CsA inhibitory effect on nuclear import of viral DNA. Therefore, the factor(s) involved in a CsA-sensitive pathway plays a critical role in HIV-1 DNA transport from the cytoplasm into the nucleus. Production and movement of HIV-1 DNA in resting CD4+ T cells require two signals: one signal from the TCR, which normally regulates the G0 to G1 transition, induces completion of viral reverse transcription; the other signal through CD28 or an IL-2R-dependent process is sensitive to CsA treatment and regulates viral DNA entry into the nucleus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8977229

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3.

Authors:  N A Glavas; C Ostenson; J B Schaefer; V Vasta; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

2.  Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes.

Authors:  S Neil; F Martin; Y Ikeda; M Collins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

Review 3.  Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy.

Authors:  Cecilia Frecha; Camille Lévy; François-Loïc Cosset; Els Verhoeyen
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

4.  Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase.

Authors:  J M Jacqué; A Mann; H Enslen; N Sharova; B Brichacek; R J Davis; M Stevenson
Journal:  EMBO J       Date:  1998-05-01       Impact factor: 11.598

5.  Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes.

Authors:  W Popik; P M Pitha
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  TLR2 activation enhances HIV nuclear import and infection through T cell activation-independent and -dependent pathways.

Authors:  Jian Ding; Theresa L Chang
Journal:  J Immunol       Date:  2011-12-30       Impact factor: 5.422

7.  CREB/ATF-dependent repression of cyclin a by human T-cell leukemia virus type 1 Tax protein.

Authors:  K V Kibler; K T Jeang
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli.

Authors:  William J Swiggard; Clifford Baytop; Jianqing J Yu; Jihong Dai; Chuanzhao Li; Richard Schretzenmair; Ted Theodosopoulos; Una O'Doherty
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

9.  Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

Authors:  T W Chun; L Stuyver; S B Mizell; L A Ehler; J A Mican; M Baseler; A L Lloyd; M A Nowak; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

10.  Multiple restrictions of human immunodeficiency virus type 1 in feline cells.

Authors:  Carsten Münk; Jörg Zielonka; Hannelore Constabel; Björn-Philipp Kloke; Benjamin Rengstl; Marion Battenberg; Francesca Bonci; Mauro Pistello; Martin Löchelt; Klaus Cichutek
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.